Skip to search formSkip to main contentSkip to account menu

AVE1625

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Hydrocarbons, HalogenatedSulfonamides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625
CB1 antagonists such as AVE1625 are potentially useful in the treatment of obesity, smoking cessation and cognitive impairment… 
2010
2010
Ligand binding sensitivity of the extracellular loop two of the cannabinoid receptor 1
The cannabinoid receptor one (CB1) is a class A G‐protein‐coupled receptor thought to bind ligands primarily within its helical… 
2010
2010
AN IN VIVO POSITRON EMISSION TOMOGRAPHY STUDY OF THE CB1 OCCUPANCY BY AVE1625 USING [C-11]-JHU75528 IN HEALTHY SUBJECTS AND IN PATIENTS WITH SCHIZOPHRENIA.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)